NEMLUVIO

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0299-6220
  • Package NDC 0299-6220-10
  • Package NDC 0299-6220-15
  • Application number BLA761390
  • SPL ID df0e2be2-b6bd-40e5-9175-0c8e893433ea
  • SPL set ID e9229ef1-ac60-4c24-afb6-009d3c781687
  • UNII GN465U8B72
  • RxCUI 2691325
  • RxCUI 2691328

What the source publishes

Labeler
Galderma Laboratories, L.P.
Active ingredients
nemolizumab-ilto
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0299-6220_df0e2be2-b6bd-40e5-9175-0c8e893433ea
{
  "name": "NEMLUVIO",
  "splId": "df0e2be2-b6bd-40e5-9175-0c8e893433ea",
  "labels": [
    {
      "setId": "e9229ef1-ac60-4c24-afb6-009d3c781687",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9229ef1-ac60-4c24-afb6-009d3c781687",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9229ef1-ac60-4c24-afb6-009d3c781687"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Galderma Laboratories, L.P.",
  "finished": true,
  "packaging": [
    {
      "sample": true,
      "description": "1 SYRINGE, GLASS in 1 CARTON (0299-6220-10)  / 30 mg in 1 SYRINGE, GLASS",
      "package_ndc": "0299-6220-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240813"
    },
    {
      "sample": false,
      "description": "1 SYRINGE in 1 CARTON (0299-6220-15)  / 30 mg in 1 SYRINGE",
      "package_ndc": "0299-6220-15",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240813"
    }
  ],
  "productId": "0299-6220_df0e2be2-b6bd-40e5-9175-0c8e893433ea",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "0299-6220",
  "deaSchedule": null,
  "genericName": "nemolizumab-ilto",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "NEMOLIZUMAB",
      "strength": "30 mg/100mg"
    }
  ],
  "applicationNumber": "BLA761390",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240813",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000194121",
      "N0000194122"
    ],
    "unii": [
      "GN465U8B72"
    ],
    "rxcui": [
      "2691325",
      "2691328"
    ],
    "spl_set_id": [
      "e9229ef1-ac60-4c24-afb6-009d3c781687"
    ],
    "pharm_class_epc": [
      "Interleukin-31 Receptor alpha Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "Interleukin-31 Receptor alpha Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Galderma Laboratories, L.P."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0299-6220_df0e2be2-b6bd-40e5-9175-0c8e893433ea"